YSYunchuang Sun

Yunchuang Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yunchuang Sun has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of visually assessed putaminal and infratentorial MRI signs with motor symptoms in multiple system atrophy: a cross-sectional study

    by Kai Li, Yang Zhao, Yiming Zheng, Mingyue Luan, Huada Tang, Chuhan He, Junyu Liu, Fan Li, Luhua Wei, Jing Chen, et al.

    Background: Visual MRI signs are widely used in multiple system atrophy (MSA), but their clinical correlates remain incompletely defined. We examined the concordance of visually assessed putaminal MRI markers and their associations with contralateral parkinsonian features, together with the relationship between infratentorial signs and cerebellar dysfunction. Methods: In this retrospective cross-sectional study, 94 patients with clinically established or clinically probable MSA (50 MSA-P, 44 MSA-C), classified according to the 2022 Movement Disorder Society criteria, underwent 3.0-T MRI. Visual markers included putaminal rim scores on diffusion-weighted imaging (DWI) and susceptibility-weighted imaging (SWI), lateral apparent diffusion coefficient (ADC) hyperintensity, and infratentorial signs. Imaging-clinical associations were examined using unadjusted analyses, age- and subtype-adjusted models, side-combined generalized estimating equation (GEE) models, and exploratory asymmetry analyses. Results: Side-specific motor scores were available for 51/94 patients and heel-knee-shin scores for 49/94. Putaminal abnormalities were more frequent in MSA-P, whereas infratentorial signs were more frequent in MSA-C. Inter-rater agreement was substantial for visual MRI markers. ADC hyperintensity showed moderate agreement with dichotomized DWI/SWI abnormalities (κ = 0.400-0.617), whereas DWI and SWI scores were strongly correlated (ρ = 0.718–0.730; p < 0.001). Unadjusted analyses suggested associations between left ADC hyperintensity and higher contralateral motor scores. In age- and subtype-adjusted models, separate side-specific putaminal models did not show significant associations with contralateral total lateral motor score, and infratentorial sign models did not show significant associations with heel-knee-shin score. However, in side-combined GEE models adjusted for age, MSA subtype, and imaging side, ADC hyperintensity and higher DWI/SWI rim scores were associated with higher contralateral total lateral motor scores ( p = 0.004, p = 0.017, and p = 0.015, respectively). Conclusions: Structured visual MRI assessment provides reproducible information for phenotypic characterization within MSA. Side-combined GEE findings suggest putaminal imaging-motor associations, but incomplete clinical assessments limit generalizability. The diagnostic value of these signs requires evaluation in comparator cohorts.

  • Open Access

    Proteomics identified carboxypeptidase E as a novel biomarker for synucleinopathies

    by Mingyue Luan, Luhua Wei, Jing Chen, Fan Li, Kai Li, Wei Sun, Fuze Zheng, Li Zhu, Zhaoxia Wang, Wei Wu, et al.

  • Open Access

    Prominent urinary dysfunction and delayed antibody detection in patients with glial fibrillary acidic protein astrocytopathy: a case series analysis

    by Zhenyu Niu, Yunchuang Sun, Fan Li, Zhaoxia Wang, Luhua Wei, Ran Liu, Feng Gao, Haiqiang Jin, Jing Guo, Nan Zhang, et al.

    Background: Glial fibrillary acidic protein astrocytopathy (GFAP-A) is a rare central nervous system (CNS) autoimmune disorder with highly heterogeneous presentations. This study aims to describe the clinical and diagnostic features in a Chinese case series. Methods: Six patients at a single tertiary center with positive GFAP antibody were included, the patients’ data were retrospectively analyzed. Results: The cohort included 3 males and 3 females, with a median age of 56 years (range 30–75). Prominent urinary dysfunction was observed in four patients (66.7%). Brain or spinal cord MRI abnormalities were present in only 50% (3/6) of patients. All patients exhibited CSF-specific oligoclonal bands and elevated indices of intrathecal IgG synthesis. A notable finding was the delayed detection of CSF GFAP antibody in five patients (83.3%), who tested negative at disease onset but turned positive upon follow-up testing weeks to months later. Conclusion: This case series underscores the high frequency of autonomic urinary dysfunction and the potential for delayed antibody detection in Chinese GFAP-A patients. These findings suggest that clinical suspicion should remain high even with initial negative antibody testing, warranting repeat CSF analysis in suspected cases to avoid diagnostic delay.


  • Generalized cortical encephalitis in autoimmune GFAP astrocytopathy

    by Yu Guo, Hongjun Hao, Yunchuang Sun

    We report a rare case of autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) presenting with generalized cortical encephalitis. A 51-year-old woman developed subacute cognitive decline and seizure. Brain MRI revealed diffuse cortical T2-FLAIR hyperintensities, sulcal effacement, cerebral edema, and diffuse leptomeningeal enhancement. Anti-GFAP antibody was detected in both serum and cerebrospinal fluid. The patient responded well to immunotherapy, with significant clinical and radiological improvement. This case further expands the phenotypic spectrum of GFAP-A and suggests potential heterogeneity in its underlying pathogenesis.


  • Skin α-synuclein assays in diagnosing Parkinson’s disease: a systematic review and meta-analysis

    by Yang Zhao, Mingyue Luan, Jing Liu, Qingqing Wang, Jianwen Deng, Zhaoxia Wang, Yunchuang Sun, Kai Li

    This systematic review and meta-analysis evaluated the diagnostic performance of skin α-synuclein (α-syn) assays, focusing on key detection techniques. A comprehensive search of PubMed, Web of Science, Embase, and Cochrane Library was conducted on April 6, 2024. Bivariate mixed-effects models were used to calculate pooled sensitivity and specificity with 95% confidence intervals (CIs) for each group and subgroup. In distinguishing Parkinson's disease (PD) from healthy controls (HCs) or non-neurodegenerative controls (NNCs), overall sensitivity and specificity were 0.78 (95% CI 0.75-0.80) and 0.96 (95% CI 0.94-0.97), with seed amplification assays (SAA) showing the highest sensitivity (0.89, 95% CI 0.85-0.93) compared to immunofluorescence (IF) (0.82, 95% CI 0.78-0.85) and immunohistochemistry (IHC) (0.70, 95% CI 0.66-0.74). For differentiating PD from multiple system atrophy (MSA), sensitivity remained high (0.80, 95% CI 0.76-0.83), but specificity was low (0.25, 95% CI 0.20-0.31); SAA, IF and IHC all obtained low pooled specificities (less than 0.3). Discriminating from tauopathies, the pooled sensitivity and specificity were 0.82 (95% CI 0.77-0.86) and 0.88 (95% CI 0.81-0.92), with immunological methods using phosphorylated α-synuclein (p-α-syn) outperforming those using non-phosphorylated α-synuclein (np-α-syn); SAA had a higher sensitivity than immunology techniques. Skin α-syn assays, particularly SAA and p-α-syn immunological methods, demonstrate strong potential as diagnostic tools for PD; SAA had a higher sensitivity than immunology techniques. However, distinguishing PD from other α-synucleinopathies is still challenging and variability across methods highlight the need for standardization. Further research should focus on integrating skin α-syn detection with other biomarkers to enhance diagnostic precision.


  • Open Access

    Myotonic Dystrophy Type 1 With Cerebellar Ataxia and Cerebellar Atrophy

    by Chen Ling, Jianchun Wang, Yiming Zheng, Yunchuang Sun

    Ling C, et al. J Clin Neurol. 2024 Sep;20(5):539-541. https://doi.org/10.3988/jcn.2024.0086

  • Open Access

    The “Black Straight-Line Sign” in the Putamen in Diffusion-Weighted Imaging: A Potential Diagnostic MRI Marker for Multiple System Atrophy

    by Yiming Zheng, Xiwen Wang, Huajian Zhao, Yanyan Jiang, Ying Zhu, Jing Chen, Wei Sun, Zhaoxia Wang, Yunchuang Sun

    Background and Purpose: The diagnosis of multiple system atrophy (MSA) remains challenging in clinical practice. This study investigated the value of hypointense signals in the putamen (“black straight-line sign”) in diffusion-weighted imaging (DWI) of brain MRI for distinguishing (MSA) from Parkinson's disease (PD).Methods: We retrospectively enrolled 30 MSA patients, 30 PD patients, and 30 healthy controls who had undergone brain MRI between 2016 and 2020. Two readers independently assessed the signal intensity of the bilateral putamen on DWI. The putaminal hypointensity was scored using 4-point visual scales. Putaminal hypointensity and the presence of a “black straight-line sign” were statistically compared between MSA and PD or healthy controls.Results: The mean scores of putaminal hypointensity in DWI in the MSA group were significantly higher than in both the PD (U = 315.5, P = 0.034) and healthy control groups (U = 304.0, P = 0.022). Uni- or bilateral putaminal hypointensity in DWI with a score ≥2 was identified in 53.3% (16/30), 16.7% (5/30), and 13.3% (4/30) of MSA, PD, and healthy controls, respectively, with significant differences between MSA and PD (X2 = 8.864, P = 0.003) or healthy controls (X2 = 10.800, P = 0.001). Notably, the “black straight-line sign” of the putamen was observed in 16/30 (sensitivity 53.3%) patients with MSA, while it was absent in PD and healthy controls (specificity 100%). There were no significant differences for the presence of “black straight-line sign” in the MSA-P and MSA-C groups (X2 = 0.433, P = 0.510).Conclusion: The “black straight-line sign” of the putamen in DWI of head MRIs has the potential to serve as a diagnostic marker for distinguishing MSA from PD.


  • Retracted
    Open Access

    [Retracted] NREM Sleep EEG Characteristics Correlate to the Mild Cognitive Impairment in Patients with Parkinsonism

    by Cheng Zhang, Luhua Wei, Fengqingyang Zeng, Tingwei Zhang, Yunchuang Sun, Yane Shen, Guangfa Wang, Jing Ma, Jue Zhang

    Early identification and diagnosis of mild cognitive impairment (MCI) in patients with parkinsonism (PDS) are critical. The aim of this study was to identify biomarkers of MCI in PDS using conventional electroencephalogram (EEG) power spectral analysis and detrended fluctuation analysis (DFA). In this retrospective study, patients with PDS who underwent an overnight polysomnography (PSG) study in our hospital from 2019 to 2020 were enrolled. Patients with PDS assessed by clinical examination and questionnaires were divided into two groups: the PDS with normal cognitive function (PDS‐NC) group and the PDS with MCI (PDS‐MCI) group. Sleep EEG signals were extracted and purified from the PSG and subjected to a conventional power spectral analysis, as well as detrended fluctuation analysis (DFA) during wakefulness, nonrapid eye movement (NREM) sleep, and rapid eye movement (REM) sleep. Forty patients with PDS were enrolled, including 25 with PDS‐NC and 15 with PDS‐MCI. Results revealed that compared with PDS‐NC patients, patients with PDS‐MCI had a reduced fast ratio ((alpha + beta)/(delta + theta)) and increased DFA during NREM sleep. DFA during NREM was diagnostic of PDS‐MCI, with an area under the receiver operating characteristic curve of 0.753 (95% CI: 0.592–0.914) (p < 0.05). Mild cognitive dysfunction was positively correlated with NREM‐DFA (r = 0.426, p = 0.007) and negatively correlated with an NREM‐fast ratio (r = −0.524, p = 0.001). This suggested that altered EEG activity during NREM sleep is associated with MCI in patients with PDS. NREM sleep EEG characteristics of the power spectral analysis and DFA correlate to MCI. Slowing of EEG activity during NREM sleep may reflect contribution to the decline in NREM physiological function and is therefore a marker in patients with PDS‐MCI.